Cyclopeptide GG-8-6 [V1A]
General Information
DRACP ID DRACP03020
Peptide Name Cyclopeptide GG-8-6 [V1A]
Sequence ALPILLLVL
Sequence Length 9
UniProt ID Not available
PubChem CID Not available
Origin Synthetic
Type Synthetic peptide
Classification
Active ACP Induce apoptosis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
SMMC-7721 | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | IC50=29.94 μM | MTT assay | 24 h | 1 |
HepG2 | Hepatoblastoma | Blastoma | IC50=29.95 μM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Not available
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Cyclic
Disulfide/Other Bond NCB: Ala1<--->Leu9
N-terminal Modification Free
C-terminal Modification Free
Other Modification None
Chiral L
Physicochemical Information
Formula C49H89N9O10
Absent amino acids CDEFGHKMNQRSTWY
Common amino acids L
Mass 110720
Pl 6.11
Basic residues 0
Acidic residues 0
Hydrophobic residues 8
Net charge 0
Boman Index 3537
Hydrophobicity 310
Aliphatic Index 303.33
Half Life
Mammalian: 100 hour
Yeast: >20 hour
E.coli: >10 hour
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 0
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 29310863
Title Synthesis and biological evaluation of cyclopeptide GG-8-6 and its analogues as anti-hepatocellular carcinoma agents
Year 2018
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_20104